trending Market Intelligence /marketintelligence/en/news-insights/trending/PP4MuHQCyzH9W5JkTgOnVA2 content esgSubNav
In This List

Moody's says Shire's evaluation of neuroscience business is credit negative

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Moody's says Shire's evaluation of neuroscience business is credit negative

Moody's believes Shire plc's announcement that it is evaluating strategic options for its neurosciences franchise could lead to changes having negative credit implications.

The rating agency believes a separation of the unit would reduce Shire's scale, diversity and earnings. There is no impact on the company's Baa3 rating or the stable rating outlook.